Mirati Therapeutics’ Collaboration and License agreement with Zai Lab Limited

Goodwin Procter LLP advised Mirati Therapeutics, Inc. on the deal.Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced its collaboration and license agreement with Zai Lab Limited (NASDAQ: ZLAB;…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Mirati Therapeutics’ Collaboration and License agreement with Zai Lab Limited

Goodwin Procter LLP advised Mirati Therapeutics, Inc. on the deal.Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced its collaboration and license agreement with Zai Lab Limited (NASDAQ: ZLAB;…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here